Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-20-010172
Filing Date
2020-03-10
Accepted
2020-03-10 21:16:34
Documents
2
Period of Report
2020-03-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6686
2 POWER OF ATTORNEY (PUBLIC): POA doc1.txt EX-24 3031
  Complete submission text file 0001127602-20-010172.txt   11046
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2010 NORTH FIRST STREET, SUITE 310 SAN JOSE CA 95131
Business Address
Cogan John Francis (Reporting) CIK: 0001319872 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 20703734